Loading peptide…
PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Vesilute, Vesilut
Vesilute is a short bioregulator peptide studied for effects on the microvasculature and skin around the eyes. It is associated with reducing periorbital puffiness and supporting capillary tone.
Sign in to rate this peptide.
Vesilute belongs to the Khavinson family of short peptide bioregulators thought to act on tissue-specific gene expression. It is associated with vascular and connective-tissue regulation, particularly in the delicate periorbital region, supporting capillary integrity and microcirculation. By modulating fibroblast and endothelial activity it is proposed to reduce fluid stasis and improve local tissue resilience. As with other Cytomax-type peptides, the postulated mechanism centers on normalizing protein synthesis in target cells.